THE GLOBAL SINGLE-USE BIOPROCESSING MARKET SIZE WAS ESTIMATED AT USD 4.8 BILLION IN 2020 AND WILL REACH USD 12 BILLION IN 2026, GROWING AT A CAGR OF 17% DURING THE FORECAST PERIOD

Single-use Bioprocessing Market Size, Share, Trends Analysis Report by Products (Single-use Bioprocessing Equipment and Simple & Peripheral Devices); Application (Monoclonal Antibodies (mABs), Vaccines, Cell Therapies, Others)); End-users (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), R&D Companies & Research Institutes); Method (Filtration, Storage & Transport, Cell Culture, Mixing, Purification); and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

319 Pages

icon-table

117 Tables

icon-chart

157 Charts

icon-region

5 Regions

icon-country

21 Countries

icon-company

47 Companies

icon-market

5 Market Segment

GLOBAL SINGLE-USE BIOPROCESSING MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) 12 BILLION (2026)
CAGR 17% (2021–2026)
Base Year 2020
Forecast Year 2021–2026
Market Segments Products (Single-use Bioprocessing Equipment and Simple & Peripheral Devices); Application (Monoclonal Antibodies (mABs), Vaccines, Cell Therapies, Others)); End-users (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), R&D Companies & Research Institutes); Method (Filtration, Storage & Transport, Cell Culture, Mixing, Purification)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Switzerland, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Columbia, Saudi Arabia, Turkey, South Africa, and UAE

SINGLE-USE BIOPROCESSING INDUSTRY INSIGHTS

The global single-use bioprocessing market size was valued at USD 4.8 billion in 2020 and is expected to reach USD 12 billion in 2026, growing at a CAGR of 17% during the forecast period. The outbreak of the COVID-19 pandemic has boosted the demand for single-use bioprocessing technology.

The ongoing robust R&D activities and clinical studies on the Covid-19 vaccine encourage many stakeholders to use SUB technology. Modalities such as covid-19 vaccine requirement, cell and gene therapies, and monoclonal antibodies are likely to influence the single-use bioprocessing market growth.  The majority of biomanufacturing companies rely on advanced technology such as single-use systems to develop the vaccine.

Single-use technology is primarily used in pre-commercial development activities, production phases, and small biotech manufacturing. Single-use solutions have already supplanted a significant portion of traditional biopharmaceutical manufacturing practices, and this trend is expected to increase in the coming years. The biopharmaceutical industry's shift from traditional stainless-steel bioprocessing equipment to single-use ones is majorly influenced by proven economic and operational benefits of single-use bioprocessing technology. The market is likely to observe significant growth as single-use technology is increasing in downstream bioprocessing.

SNIPPETS

  • SUB market is expected to observe an incremental growth of over USD 4 billion on account of high safety profile and flexibility in pre-commercial production processes.
  • Vaccines are likely to grow at the fastest CAGR during the forecast period due to the shift from traditional vaccine production to SUB-based manufacturing.
  • Monoclonal bodies are projected to reach a revenue share of approx. $5 billion by 2026 due to the adoption of SUB in manufacturing increases potential feasibility, cost-effectiveness, and reduced staff overheads.
  • Contract manufacturing organizations (CMO) are likely to grow at the fastest CAGR of over 17% during 2020­–2026 because of the high adoption of SUBs by CMOs for biopharmaceuticals manufacturing.
  • The cell culture segment is expected to witness an incremental growth of over $2 billion by 2026 due to tremendous advances in human and cell cultures.
  • The U.S. single-use bioprocessing market is expected to grow at a CAGR of approx. 17% during 2020­-2026. 

GLOBAL SINGLE-USE BIOPROCESSING MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Product
  • Application
  • End-user
  • Method
  • Geography

INSIGHTS BY PRODUCT

Single-use bioprocessing products observe growth due to advances in equipment, higher scalability, and the increased application in the biopharmaceutical industry. Bioreactors and fermenters cover significant shares among SUB. The use of bioreactors and fermenters is growing for the development of biosimilars & biologics. The availability of single-use chromatography systems is considered a solution for single-use downstream bioprocessing. The use of membrane formats, scaling technologies, ion exchange technology, and polymeric column constructions are shifting end-users toward SUBs in downstream processes. Chromatography systems combined with tangential flow filtrations provide the highest productivity in downstream separation and purification steps.

Simple & peripheral elements accounted for over 45% single-use bioprocessing market share. The recurring use of tubing and filling, connectors, bags, sampling devices, probes and sensors, bottle assemblies, and manifolds is responsible for these devices' growth. Connectors, filling and tubing, and filters occupy a significant portion of the market share. Single-use connectors and tubing are prioritized for advanced aseptic processing, enabling reliability, flexibility, and cost-efficiency. Biopharmaceutical and pharmaceutical industries are currently relying on single-use solutions for the upstream process. However, with recent advances and increased SUB penetration, end-users are likely to use single-use technologies for commercial purposes. As this equipment is single-use in nature, the sales of simple and peripheral devices are rapidly increasing, thereby increasing their revenue shares.

INSIGHTS BY APPLICATION

The increased application of monoclonal antibodies (mABs) to diagnose and treat autoimmune disorders, cancer, and sexually transmitted infections (STIs) is boosting the single-use bioprocessing market growth. The production of mABs via single-use bioreactors reduces the operating cost and offers more flexibility than traditional stainless steel equipment. Also, the use of SUB in mABs manufacturing increases capacity, productivity, and flexibility. The utilization of SUBs in vaccine manufacturing is catching pace and is considered the smart method, especially during pandemics. They have become an ideal choice among manufacturers as they can be manufactured quickly and do not require validation, and have a reduced risk of contamination. Furthermore, single-use systems help enhance flexibility in small and large vaccine manufacturing and produce multiple products in a single suite.

Vaccine manufacturing via SUB has shifted to a large scale due to the increasing demand for high capacities. With the outbreak of the covid-19 pandemic, single-use technology has emerged as a critical factor for the rapid production of the COVID-19 vaccine in a short time. In addition to covid-19 vaccine production, single-use technology is finding application in the manufacturing of other vaccines such as influenza, thereby influencing the market growth.

INSIGHTS BY END-USER

Biopharmaceutical manufacturers occupy a significant share of the market, with single-use systems witnessing adoption in pre-commercial production processes. Several biopharmaceutical manufacturers have started to explore these solutions in commercial manufacturing. However, their potential benefits are significant, particularly for small-volume manufacturing in modular facilities. With the advent of single-use bioprocessing, the bioprocessing industry's dynamics have changed, enabling companies to develop new biologics with higher flexibility and low upfront costs. As technology has become increasingly popular, many companies are becoming interested in the widespread adoption of single-use bioprocessing.

In 2020, contract manufacturing organizations (CMO) accounted for over 34% share in the single-use bioprocessing market. Currently, over 10% of bioprocessing worldwide - about 1.7 million liters rely on single-use systems. It is expected that single-use covers 25–30% of the bioprocessing market in the future. CMOs use more SUB than biopharmaceutical developers as they offer quick switching over process lines and increased flexibility. Moreover, CMOs implementing SUB are likely to save on operating costs, capital investments, and floor space & process lines.

INSIGHTS BY METHOD

Advances in the cell culture process and biopharmaceutical manufacturing are leading to the development of innovative single-use technology. Single-use bioreactors are increasingly used for animal and human cell production processes. SUBs in mammalian cell culture result in high flexibility, reduced cost, and enhanced product productivity. They are increasingly being used for small-batch, large-batch volumes, clinical trials, and process development.

Filtration contributes to over 30% shares of the market. The application of disposable products is increasing from downstream sterilization and purification to upstream depth filtration and clarification. Single-use systems are used in membrane absorption and viral clearance. Single-use depth filters are applied to clarify cell culture streams in the first step of the downstream process. The increased demand for advanced filtration techniques is growing with growing challenges in the downstream bioprocessing and improvements in the biomass concentration during biologics manufacturing.

INSIGHTS BY GEOGRAPHY

North America and Europe constitute over 75% of the market share; however, the APAC region is expected to grow at the fastest CAGR of over 19% during 2020-2026. The increasing spending on biopharmaceutical research activities in the US and Canada, large-scale manufacturing facilities, and the growing demand for single-use technology contribute to the region's growth.

Similarly, in Europe, the increasing adoption of disposable bioprocessing, increasing biopharmaceutical manufacturing, and growing chronic diseases across Europe are significant drivers influencing the market growth. However, the APAC region is poised for growth. It is likely to grow at the fastest CAGR during the forecast period because of the growth in the R&D infrastructure, increase in the awareness of disposables, expiry of blockbuster biologics, favorable government initiatives, and increased demand for biologics.

INSIGHTS BY VENDORS

Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Danaher Corporation, and Avantor are the key vendors operating in the global single-use bioprocessing market. The key players are increasing their focus on mergers and acquisitions in the past few years. With the sudden onset of the COVID-19 pandemic, vendors target vaccine developers and offer customized and flexible SUB technology. Acquisitions of emerging/small, specialized single-use suppliers, product portfolio development, expansion in regional markets, and strengthening of global distribution networks are the major strategies adopted by vendors in the market.

The global single-use bioprocessing market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Product

  • Single-use Bioprocessing Equipment
  • Simple & Peripheral Devices

Application

  • Monoclonal Antibodies (mABs)
  • Vaccines
  • Cell Therapies
  • Others

End-users

  • Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • R&D Companies & Research Institutes

Method

  • Filtration
  • Storage & Transport
  • Cell Culture
  • Mixing
  • Purification

Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • South Africa
    • UAE

Frequently Asked Questions

How big is the single-use bioprocessing market?

The global single-use bioprocessing market size was valued at USD 4.8 billion in 2020 and is expected to reach USD 12 billion in 2026

What is the single-use bioprocessing market growth?

The SUB market is expected to grow at a CAGR of 17% during 2021-2026

What segments are covered in the Single-use Bioprocessing Market report?

This research report includes a detailed segmentation by, Product, Application, End-user, Method, Geography

Who are the key players in the market? What are significant acquisitions & collaborations witnessed in the market?

Thermo Fisher Scientific, Sartorius Stedim Biotech, Danaher, Merck KGaA, and Avantor are the key players in the market. A selected life science businesses acquisition of Danaher Corporation by Sartorius Stedim Biotech on April 30, 2020 was a significant strategic acquisition, which is likely to complement the portfolio lineups of both Sartorius divisions.

Which region is likely to be the highest revenue generator in the market?

North America is expected to emerge as the largest revenue contributor to the market, expecting to cross approx. $5 billion.

What are the factors driving the growth of the single-use bioprocessing market during the forecast period?

High utilization of single-use bioprocessing for covid-19 vaccine production and the increasing adoption of single-use technologies over multi-use bioprocessing platforms are the major factors expecting to contribute to the market growth.

Download Free Sample

The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during 2021–2026.

The following factors are likely to contribute to the growth of the single-use bioprocessing market during the forecast period:

  • Increasing Strategic Acquisitions & Partnerships
  • New Product Launches
  • High Utilization of Single-use Bioprocessing for Covid-19 Vaccine Production
  • Technological Advances in SUB

Base Year:                  2020

Forecast Year:           2021–2026

The study considers the global single-use bioprocessing market’s present scenario and its market dynamics for 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Thermo Fisher Scientific
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Sartorius Stedim Biotech
  • Danaher
  • Merck KGaA
  • Avantor

Other Prominent Vendors

  • Applikon Biotechnology
    • Business Overview
    • Product Offerings
  • Eppendorf
  • CESCO Bioengineering
  • Corning
  • Rentschler Biopharma SE
  • Entegris
  • Meissner Filtration Products
  • Parker-Hannifin Corporation
  • PBS Biotech Inc.
  • Saint-Gobain
  • Sentinel Process Systems
  • ABEC
  • Adolf Kühner
  • Charter Medical
  • Holland Applied Technologies
  • Repligen
  • Solaris Biotech Solutions
  • 3M Company
  • Lonza
  • Pneumatic Scale Angelus
  • ARTeSYN Biosolutions
  • Wego Group
  • Distek
  • New Horizon Biotech
  • OmniBRx Biotechnologies
  • Yposkesi
  • Charge Point Technology
  • High Purity New England
  • PendoTECH
  • AdvantaPure
  • TBL Performance Plastics
  • Cellon
  • Sysbiotech
  • Broadley-James
  • CerCell A/S
  • PreSens-Precision Sensing GmbH
  • Emerson Electric Co.
  • Colder Products Company (CPC)
  • Watson-Marlow Fluid Technology Group
  • Foxx Life Sciences
  • DrM (Dr. Mueller AG)
  • W.L. Gore & Associates

Product

  • Single-use Bioprocessing Equipment
  • Simple & Peripheral Devices

Application

  • Monoclonal Antibodies (mABs)
  • Vaccines
  • Cell Therapies
  • Others

End-users

  • Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • R&D Companies & Research Institutes

Method

  • Filtration
  • Storage & Transport
  • Cell Culture
  • Mixing
  • Purification

Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • South Africa
    • UAE

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of The Study

4.3.1 Market Segmentation By Product

4.3.2 Market Segmentation By Application

4.3.3 Market Segmentation By End-User

4.3.4 Market Segmentation By Method

4.3.5 Market Segmentation By Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Overview

7.2 Single-Use Bioprocessing: Market Snapshot

8 Market Opportunities & Trends

8.1 Increasing Strategic Acquisitions & Partnerships

8.2 New Product Launches

8.3 High Utilization of Single-Use Bioprocessing For COVID-19 Vaccine Production

8.4 Technological Advances Witnessed In SUB

9 Market Growth Enablers

9.1 Increasing Adoption of Single-Use Technologies Over Multi-Use Platforms

9.2 Reduced Water Consumption and Lesser Environment Impact Of Single-Use Technologies

9.3 Lower Risk of Cross Contamination and Lower Manufacturing Cost

9.4 High Uptake of Biopharmaceuticals & Biosimilars

9.5 Increasing Demand for Flexible Bioprocessing And Less Floor Space Requirements

10 Market Restraints

10.1 Leachables & Extractables With Single-Use Bioprocessing

10.2 High-Cost of Single-Use Bioprocessing

10.3 Challenges With Scalability, Product Compatibility And Compliance

10.4 Regulatory Uncertainties Impacting the Adoption of Single-Use Bioprocessing

11 Market Landscape

11.1 Market Overview

11.1.1 Impact of COVID-19 on the Single-Use Bioprocessing Market

11.2 Market Size & Forecast

11.3 Five Forces Analysis

11.3.1 Threat of New Entrants

11.3.2 Bargaining Power of Suppliers

11.3.3 Bargaining Power of Buyers

11.3.4 Threat of Substitutes

11.3.5 Competitive Rivalry

12 Product

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Single-Use Bioprocessing Equipment

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.4 Simple & Peripheral Elements

12.4.1 Market Overview

12.4.2 Market Size & Forecast

13 Application

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Monoclonal Antibodies

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.4 Vaccines

13.4.1 Market Overview

13.4.2 Market Size & Forecast

13.5 Cell Therapies

13.5.1 Market Overview

13.5.2 Market Size & Forecast

13.6 OTHERS

13.6.1 Market Overview

13.6.2 Market Size & Forecast

14 End-User

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Biopharmaceutical Manufacturers

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.4 CMOs

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.5 R&D Companies and Research Institutes

14.5.1 Market Overview

14.5.2 Market Size & Forecast

15 Method

15.1 Market Snapshot & Growth Engine

15.2 Market Overview

15.3 Filtration

15.3.1 Market Overview

15.3.2 Market Size & Forecast

15.4 Storage & Transport

15.4.1 Market Overview

15.4.2 Market Size & Forecast

15.5 Cell Culture

15.5.1 Market Overview

15.5.2 Market Size & Forecast

15.6 Mixing

15.6.1 Market Overview

15.6.2 Market Size & Forecast

15.7 Purification

15.7.1 Market Overview

15.7.2 Market Size & Forecast

16 Geography

16.1 Market Snapshot & Growth Engine

16.2 Geographic Overview

17 North America

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Product Segmentation

17.4 Application Segmentation

17.5 End-User Segmentation

17.6 Key Countries

17.6.1 US: Market Size & Forecast

17.6.2 Canada: Market Size & Forecast

18 Europe

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Product Segmentation

18.4 Application Segmentation

18.5 End-User Segmentation

18.6 Key Countries

18.6.1 Germany: Market Size & Forecast

18.6.2 France: Market Size & Forecast

18.6.3 Switzerland: Market Size & Forecast

18.6.4 UK: Market Size & Forecast

18.6.5 Italy: Market Size & Forecast

18.6.6 Spain: Market Size & Forecast

19 APAC

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Product Segmentation

19.4 Application Segmentation

19.5 End-User Segmentation

19.6 Key Countries

19.6.1 China: Market Size & Forecast

19.6.2 Japan: Market Size & Forecast

19.6.3 Australia: Market Size & Forecast

19.6.4 South Korea: Market Size & Forecast

19.6.5 India: Market Size & Forecast

20 Latin America

20.1 Market Overview

20.2 Market Size & Forecast

20.3 Product Segmentation

20.4 Application Segmentation

20.5 End-User Segmentation

20.6 Key Countries

20.6.1 Brazil: Market Size & Forecast

20.6.2 Mexico: Market Size & Forecast

20.6.3 Colombia: Market Size & Forecast

20.6.4 Argentina: Market Size& Forecast

21 Middle East & Africa

21.1 Market Overview

21.2 Market Size & Forecast

21.3 Product Segmentation

21.4 Application Segmentation

21.5 End-User Segmentation

21.6 Key Countries

21.6.1 Turkey: Market Size & Forecast

21.6.2 Saudi Arabia: Market Size & Forecast

21.6.3 UAE: Market Size & Forecast

21.6.4 South Africa: Market Size & Forecast

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW

22.2 MARKET SHARE ANALYSIS

22.2.1 Thermo Fisher Scientific

22.2.2 Sartorius Stedim Biotech

22.2.3 Danaher

22.2.4 Merck KGaA

22.2.5 Avantor

23 Key Company Profiles

23.1 Thermo Fisher Scientific

23.1.1 Business Overview

23.1.2 Product Offerings

23.1.3 Key Strategies

23.1.4 Key Strengths

23.1.5 Key Opportunities

23.2 Sartorius Stedim Biotech

23.2.1 Business Overview

23.2.2 Product Offerings

23.2.3 Key Strategies

23.2.4 Key Strengths

23.2.5 Key Opportunities

23.3 Danaher

23.3.1 Business Overview

23.3.2 Product Offerings

23.3.3 Key Strategies

23.3.4 Key Strengths

23.3.5 Key Opportunities

23.4 MERCK KGaA

23.4.1 Business Overview

23.4.2 Product Offerings

23.4.3 Key Strategies

23.4.4 Key Strengths

23.4.5 Key Opportunities

23.5 Avantor

23.5.1 Business Overview

23.5.2 Product Offerings

23.5.3 Key Strategies

23.5.4 Key Strengths

23.5.5 Key Opportunities

24 Other Prominent Vendors

24.1 Applikon Biotechnology

24.1.1 Business Overview

24.1.2 Product Offerings

24.2 EPPENDORF

24.2.1 Business Overview

24.2.2 Product Offerings

24.3 CESCO Bioengineering

24.3.1 Business Overview

24.3.2 Product Offerings

24.4 Corning

24.4.1 Business Overview

24.4.2 Product Offerings

24.5 Rentschler Biopharma SE

24.5.1 Business Overview

24.5.2 Product Offerings

24.6 ENTEGRIS

24.6.1 Business Overview

24.6.2 Product Offerings

24.7 Meissner Filtration Products

24.7.1 Business Overview

24.7.2 Product Offerings

24.8 Parker-Hannifin Corporation

24.8.1 Business Overview

24.8.2 Product Offering

24.9 PBS Biotech

24.9.1 Business Overview

24.9.2 Product Offerings

24.10 Saint-Gobain

24.10.1 Business Overview

24.10.2 Product Offerings

24.11 Sentinel Process Systems

24.11.1 Business Overview

24.11.2 Product Offerings

24.12 ABEC

24.12.1 Business Overview

24.12.2 Product Offerings

24.13 ADOLF KÜHNER

24.13.1 Business Overview

24.13.2 Product Offerings

24.14 Charter Medical

24.14.1 Business Overview

24.14.2 Product Offerings

24.15 Holland Applied Technologies

24.15.1 Business Overview

24.15.2 Product Offerings

24.16 Repligen

24.16.1 Business Overview

24.16.2 Product Offerings

24.17 Solaris Biotech Solutions

24.17.1 Business Overview

24.17.2 Product Offerings

24.18 3M Company

24.18.1 Business Overview

24.18.2 Product Offerings

24.19 LONZA

24.19.1 Business Overview

24.19.2 Product Offerings

24.20 Pneumatic Scale Angelus

24.20.1 Business Overview

24.20.2 Product Offering

24.21 Artesyn Biosolutions

24.21.1 Business Overview

24.21.2 Product Offerings

24.22 Wego Group

24.22.1 Business Overview

24.22.2 Product Offerings

24.23 DISTEK

24.23.1 Business Overview

24.23.2 Product Offerings

24.24 New Horizon Biotech

24.24.1 Business Overview

24.24.2 Product Offerings

24.25 Omnibrx Biotechnologies

24.25.1 Business Overview

24.25.2 Product Offerings

24.26 YPOSKESI

24.26.1 Business Overview

24.26.2 Product Offering

24.27 Charge Point Technology

24.27.1 Business Overview

24.27.2 Product Offerings

24.28 High Purity New England

24.28.1 Business Overview

24.28.2 Product Offerings

24.29 Pendotech

24.29.1 Business Overview

24.29.2 Product Offerings

24.30 Advantapure

24.30.1 Business Overview

24.30.2 Product Offerings

24.31 TBL Performance Plastics

24.31.1 Business Overview

24.31.2 Product Offerings

24.32 CELLON

24.32.1 Business Overview

24.32.2 Product Offerings

24.33 SYSBIOTECH

24.33.1 Business Overview

24.33.2 Product Offerings

24.34 Broadley-James

24.34.1 Business Overview

24.34.2 Product Offerings

24.35 Cercell

24.35.1 Business Overview

24.35.2 Product Offerings

24.36 Presens-Precision Sensing

24.36.1 Business Overview

24.36.2 Product Offerings

24.37 Emerson Electric

24.37.1 Business Overview

24.37.2 Product Offerings

24.38 CPC

24.38.1 Business Overview

24.38.2 Product Offerings

24.39 Watson-Marlow Fluid Technology Group

24.39.1 Business Overview

24.39.2 Product Offerings

24.40 Foxx Life Sciences

24.40.1 Business Overview

24.40.2 Product Offerings

24.41 DRM

24.41.1 Business Overview

24.41.2 Product Offerings

24.42 W.L. Gore & Associates

24.42.1 Business Overview

24.42.2 Product Offerings

25 Report Summary

25.1 Key Takeaways

25.2 Strategic Recommendations

26 Quantitative Summary

26.1 Market by Product

26.1.1 SUB Equipment: Geography Segmentation

26.1.2 Simple & Peripheral Elements: Geography Segmentation

26.2 Market by Application

26.2.1 Monoclonal Antibodies: Geography Segmentation

26.2.2 Vaccines: Geography Segmentation

26.2.3 Cell Therapies: Geography Segmentation

26.2.4 Others: Geography Segmentation

26.3 Market by End-User

26.3.1 Biopharmaceutical Manufacturers: By Geography

26.3.2 CMOs: Geography Segmentation

26.3.3 R&D Companies and Research Institutes: Geography Segmentation

26.4 Market by Method

26.5 Market by Geography

26.5.1 North America: Product Segmentation

26.5.2 Europe: Product Segmentation

26.5.3 APAC: Product Segmentation

26.5.4 Latin America: Product Segmentation

26.5.5 Middle East & Africa: Product Segmentation

26.5.6 North America: Application Segmentation

26.5.7 Europe: Application Segmentation

26.5.8 APAC: Application Segmentation

26.5.9 Latin America: Application Segmentation

26.5.10 Middle East & Africa: Application Segmentation

26.5.11 North America: End-User Segmentation

26.5.12 Europe: End-User Segmentation

26.5.13 APAC: End-user Segmentation

26.5.14 Latin America: End-User Segmentation

26.5.15 Middle East & Africa: End-User Segmentation

27 Appendix

27.1 Abbreviations

List of Exhibits 

Exhibit 1             Segmentation of Global Single-use Bioprocessing Market

Exhibit 2             Market Size Calculation Approach 2020

Exhibit 3             Impact of Increasing Strategic Acquisitions & Partnerships

Exhibit 4             Impact of New Product Launches

Exhibit 5             Areas of Interests in the New Product Development by Biotherapeutic Developers & CMOs

Exhibit 6             Impact of High Utilization of Single-use Bioprocessing for COVID-19 Vaccine Production

Exhibit 7             Long-term Effects of COVID-19 on Single-use Bioprocessing

Exhibit 8             Impact of Technological Advances Witnessed in SUB

Exhibit 9             Impact of Increasing Adoption of Single-use Technologies Over Multi-use Bioprocessing Platforms

Exhibit 10           Advantages of Single-use Bioprocessing

Exhibit 11           Comparison of Several Parameters for Single-use and Traditional Manufacturing Technology (%)

Exhibit 12           Usage of Single-use Bioprocessing by Developers and CMOs

Exhibit 13           Impact of Reduced Water Consumption and Lesser Environment Impact of Single-use Technologies

Exhibit 14           Comparison of Water and Energy Consumption by Single-use and Conventional Systems

Exhibit 15           Environmental Impact of Single-use and Traditional Biopharmaceutical Manufacturing Technology

Exhibit 16           Lifecycle Endpoint Impact of Single-use and Traditional Systems

Exhibit 17           Impact of Lower Risk of Cross Contamination and Lower Manufacturing Cost

Exhibit 18           Investment Cost Reduction Associated with Single-use Installation in Upstream Bioprocessing

Exhibit 19           Impact of High Uptake of Biopharmaceuticals & Biosimilars

Exhibit 20           Uptake of Biosimilars in Various Countries

Exhibit 21           Biologics Sales Worldwide (%)

Exhibit 22           Impact of Increasing Demand for Flexible Bioprocessing and Lesser Floor Space Requirements

Exhibit 23           Percentage of Space Reduction by Single-use Systems Compared with Traditional Systems

Exhibit 24           Impact of Leachables & Extractables with Single-use Bioprocessing

Exhibit 25           Concern of Leachables and Extractables by CMOs and Biotherapeutic Developers

Exhibit 26           Impact of High-Cost of Single-Use Bioprocessing

Exhibit 27           Percentage Restriction of SUS by CMOs and Biotherapeutic Developers

Exhibit 28           Reasons Obstructing the Usage of Single-use Bioprocessing

Exhibit 29           Impact of Challenges with Scalability, Product Compatibility and Compliance

Exhibit 30           Challenges Concerning Implementation of Single-Use Bioprocessing System

Exhibit 31           Impact of Regulatory Uncertainties Impacting the Adoption of Single-Use Bioprocessing

Exhibit 32           Global Single-use Bioprocessing Market 2020–2026 ($ million)

Exhibit 33           Global Single-use Bioprocessing Market by Geography

Exhibit 34           Global Single-use Bioprocessing Market by Product

Exhibit 35           Global Single-use Bioprocessing Market by Application

Exhibit 36           Global Single-use Bioprocessing Market by End-user

Exhibit 37           Global Single-use Bioprocessing Market by Method

Exhibit 38           Five Forces Analysis 2020

Exhibit 39           Incremental Growth by Product 2020 & 2026

Exhibit 40           Global Single-use Bioprocessing Market by Product

Exhibit 41           Global Single-use Bioprocessing Market by Product: Incremental Growth Comparison ($ million)

Exhibit 42           Global Single-use Bioprocessing Market by Product: Absolute Growth Comparison (%)

Exhibit 43           Global Single-use Bioprocessing Market by Single-use Bioprocessing Equipment 2020−2026 ($ million)

Exhibit 44           Global Single-use Bioprocessing Market by Simple & Peripheral Elements 2020-2026 ($ million)

Exhibit 45           Incremental Growth by Application 2020 & 2026

Exhibit 46           Global Single-use Bioprocessing Market by Application

Exhibit 47           Global Single-use Bioprocessing Market by Application: Incremental Growth Comparison ($ million)

Exhibit 48           Global Single-use Bioprocessing Market by Application: Absolute Growth Comparison (%)

Exhibit 49           Global Single-use Bioprocessing Market by Monoclonal Antibodies 2020–2026 ($ million)

Exhibit 50           Global Single-use Bioprocessing Market by Vaccines 2020–2026 ($ million)

Exhibit 51           Global Single-use Bioprocessing Market by Cell Therapies 2020–2026 ($ million)

Exhibit 52           Global Single-use Bioprocessing Market by Other Applications 2020−2026 ($ million)

Exhibit 53           Incremental Growth by End-User 2020 & 2026

Exhibit 54           Global Single-use Bioprocessing Market by End-user

Exhibit 55           Global Single-use Bioprocessing Market by End-user: Incremental Growth Comparison ($ million)

Exhibit 56           Global Single-use Bioprocessing Market by End-user: Absolute Growth Comparison (%)

Exhibit 57           Global Single-use Bioprocessing Market by Biopharmaceutical Manufacturers 2020−2026 ($ million)

Exhibit 58           Adoption of SUBs by CMOs and Biopharmaceutical Developers

Exhibit 59           Global Single-use Bioprocessing Market by CMOs 2020−2026 ($ million)

Exhibit 60           Global Single-use Bioprocessing Market by R&D Companies and Research Institutes 2020−2026 ($ million)

Exhibit 61           Incremental Growth by Method 2020 & 2026

Exhibit 62           Global Single-use Bioprocessing Market by Method

Exhibit 63           Global Single-use Bioprocessing Market by Method: Incremental Growth Comparison ($ million)

Exhibit 64           Global Single-use Bioprocessing Market by Method: Absolute Growth Comparison (%)

Exhibit 65           Global Single-use Bioprocessing Market by Filtration 2020−2026 ($ million)

Exhibit 66           Global Single-use Bioprocessing Market by Storage & Transport 2020−2026 ($ million)

Exhibit 67           Global Single-use Bioprocessing Market by Cell Culture 2020−2026 ($ million)

Exhibit 68           Global Single-use Bioprocessing Market by Mixing 2020−2026 ($ million)

Exhibit 69           Global Single-use Bioprocessing Market by Purification 2020−2026 ($ million)

Exhibit 70           Incremental Growth by Geography 2020 & 2026

Exhibit 71           Global Single-use Bioprocessing Market by Geography

Exhibit 72           Global Single-use Bioprocessing Market by Geography: Incremental Growth Comparison ($ million)

Exhibit 73           Global Single-use Bioprocessing Market by Geography: Absolute Growth Comparison (%)

Exhibit 74           Global Biopharmaceutical Manufacturing Facilities

Exhibit 75           Single-use Bioprocessing Market in North America 2020–2026 ($ million)

Exhibit 76           Incremental Growth by Product 2020 & 2026

Exhibit 77           Incremental Growth by Application 2020 & 2026

Exhibit 78           Incremental Growth by End-user 2020 & 2026

Exhibit 79           Incremental Growth in North America 2020 & 2026

Exhibit 80           Biopharmaceutical Research and Development Expenditure in US 2011 & 2019 ($ billion)

Exhibit 81           Comparison of Number of Biopharmaceutical Manufacturing Facilities in US, China, and India

Exhibit 82           Single-use Bioprocessing Market in US 2020–2026 ($ million)

Exhibit 83           Increasing Prevalence of Major Chronic Diseases in Canada

Exhibit 84           Cumulative Number of Biologics Approved by Health Canada 2015, 2017, & 2019

Exhibit 85           Single-use Bioprocessing Market in Canada 2020–2026 ($ million)

Exhibit 86           Comparison of Number of Approved Biosimilars in US and Europe

Exhibit 87           No. of Companies Involved in R&D Activities in the US, Europe & China

Exhibit 88           Single-use Bioprocessing Market in Europe 2020–2026 ($ million)

Exhibit 89           Incremental Growth by Product 2020 & 2026

Exhibit 90           Incremental Growth by Application 2020 & 2026

Exhibit 91           Incremental Growth by End-user 2020 & 2026

Exhibit 92           Incremental Growth in Europe 2020 & 2026

Exhibit 93           Prevalence of Chronic Diseases in Germany (%)

Exhibit 94           Global Biologics Delivered by Country (%)

Exhibit 95           Single-use Bioprocessing Market in Germany 2020−2026 ($ million)

Exhibit 96           Single-use Bioprocessing Market in France 2020−2026 ($ million)

Exhibit 97           Increasing Aging Demographics in Switzerland 2008, 2030, & 2045 (million)

Exhibit 98           Single-use Bioprocessing Market in Switzerland 2020−2026 ($ million)

Exhibit 99           Burden of Chronic Diseases in UK (%)

Exhibit 100        Single-use Bioprocessing Market in UK 2020−2026 ($ million)

Exhibit 101        Percentage Share of Chronic Diseases in Italy

Exhibit 102        High-research Intensive Biotechnological Industry in Italy

Exhibit 103        Single-use Bioprocessing Market in Italy 2020−2026 ($ million)

Exhibit 104        Prevalence of Chronic Diseases in the Spanish Population

Exhibit 105        Gross Domestic Research & Development Expenditure in Spain 2016 to 2019 (%)

Exhibit 106        Single-use Bioprocessing Market in Spain 2020−2026 ($ million)

Exhibit 107        Percentage of Deaths due to Chronic Diseases in South East Asia

Exhibit 108        Number of Biologics Patent Expiries and Sales at Risk from 2015–2030 ($ billion)

Exhibit 109        Single-use Bioprocessing Market in APAC 2020−2026 ($ million)

Exhibit 110        Incremental Growth by Product 2020 & 2026

Exhibit 111        Incremental Growth by Application 2020 & 2026

Exhibit 112        Incremental Growth by End-user 2020 & 2026

Exhibit 113        Incremental Growth in APAC 2020 & 2026

Exhibit 114        Prevalence Rates of Chronic Diseases in Rural Chinese Population

Exhibit 115        Research and Development Investment in China 2018 & 2019 ($ billion)

Exhibit 116        Single-use Bioprocessing Market in China 2020−2026 ($ million)

Exhibit 117        Prevalence of Chronic Diseases in Japan’s Elderly Population

Exhibit 118        Research & Development Expenditure in Japan by % Share GDP

Exhibit 119        Single-use Bioprocessing Market in Japan 2020−2026 ($ million)

Exhibit 120        Percentage Share of Aged 65 Years & Above Over Past Decade in Australia (%)

Exhibit 121        Single-use Bioprocessing Market in Australia 2020−2026 ($ million)

Exhibit 122        Percentage Prevalence of Disease Conditions in South Korea

Exhibit 123        Single-use Bioprocessing Market in South Korea 2020−2026 ($ million)

Exhibit 124        Percentage of Individuals Suffering from One or More Chronic Conditions by Age and Gender

Exhibit 125        Single-use Bioprocessing Market in India 2020−2026 ($ million)

Exhibit 126        Percentage of Aging Population in Latin America 2010−2050 (%)

Exhibit 127        Single-use Bioprocessing Market in Latin America 2020−2026 ($ million)

Exhibit 128        Incremental Growth by Product 2020 & 2026

Exhibit 129        Incremental Growth by Application 2020 & 2026

Exhibit 130        Incremental Growth by End-user 2020 & 2026

Exhibit 131        Incremental Growth in Latin America 2020 & 2026

Exhibit 132        Increasing Aging Population in Brazil from 2012 to 2050 (million)

Exhibit 133        Single-use Bioprocessing Market in Brazil 2020−2026 ($ million)

Exhibit 134        Estimated Increasing Trends in Breast and Lung Cancer in Mexicans

Exhibit 135        Single-use Bioprocessing Market in Mexico 2020−2026 ($ million)

Exhibit 136        Burden of Chronic NCDs in Colombia in Accordance with Age

Exhibit 137        Single-use Bioprocessing Market in Colombia 2020−2026 ($ million)

Exhibit 138        Growing Elderly Population from 2019 to 2100 in Argentina

Exhibit 139        Single-use Bioprocessing Market in Argentina 2020−2026 ($ million)

Exhibit 140        Number of Patient Population Suffering from Chronic Diseases in Middle East and Africa (million)

Exhibit 141        Single-use Bioprocessing Market in Middle East & Africa 2020−2026 ($ million)

Exhibit 142        Incremental Growth by Product 2020 & 2026

Exhibit 143        Incremental Growth by Application 2020 & 2026

Exhibit 144        Incremental Growth by End-user 2020 & 2026

Exhibit 145        Incremental Growth in Middle East & Africa 2020 & 2026

Exhibit 146        Prevalence of Chronic Kidney Disease Among Obese Population in Turkey

Exhibit 147        Single-use Bioprocessing Market in Turkey 2020−2026 ($ million)

Exhibit 148        Percentage Burden of Chronic Diseases in Saudi Arabia (%)

Exhibit 149        Single-use Bioprocessing Market in Saudi Arabia 2020−2026 ($ million)

Exhibit 150        Prevalence of Diabetes in UAE Based on Gender and Age

Exhibit 151        Single-use Bioprocessing Market in UAE 2020−2026 ($ million)

Exhibit 152        Prevalence of Various Chronic Diseases in South Africa

Exhibit 153        Single-use Bioprocessing Market in South Africa 2020−2026 ($ million)

Exhibit 154        Thermo Fisher Scientific Revenue 2017−2019 ($ million)

Exhibit 155        Thermo Fisher Scientific Revenue Share by Segments in FY2018 & 2019 ($ million)

Exhibit 156        Thermo Fisher Scientific Revenue Share by Region 2018 & 2019 ($ million)

Exhibit 157        Thermo Fisher Scientific R&D Investments from FY2017−2019 ($ million)

Exhibit 158        Sartorius Stedim Biotech Total Revenue from FY2017−2019 ($ million)

Exhibit 159        Sartorius Stedim Biotech R&D Investments 2017−2019 ($ million)

Exhibit 160        Sartorius Stedim Biotech Revenue Share by Regions 2018& 2019 ($ million)

Exhibit 161        Danaher Revenue FY2017−2019 ($ million)

Exhibit 162        Danaher Revenue Share by Segments in 2018 & 2019 ($ million)

Exhibit 163        Danaher Revenue Generated by Geographic Regions 2018 & 2019 ($ million)

Exhibit 164        Danaher R&D Investment 2017−2019 ($ million)

Exhibit 165        Merck KGaA Total Revenue Generated (FY2017−2019) ($ million)

Exhibit 166        Merck KGaA Revenue Generated by Segments in FY2018 & 2019 ($ million)

Exhibit 167        Merck KGaA Revenue Share by Regions 2018 & 2019 ($ million)

Exhibit 168        Merck KGaA R&D Investment FY2017−2019 ($ million)

Exhibit 169        Avantor Total Revenue FY2017−2019 ($ million)

Exhibit 170        Avantor Revenue Share by Segment based on Geography 2018& 2019 ($ million)

             

List Of Tables   

Table 1               Key Caveats

Table 2               Currency Conversion 2013−2020

Table 3               Comparison of Single-use Bioprocessing & Traditional Stainless-steel Bioprocessing

Table 4               Key Strategic Acquisitions & Partnerships in Single-use Bioprocessing

Table 5               Companies Launching New Single-use Bioprocessing Products

Table 6               Difference between Single-use Manufacturing Facility & Conventional Stainless Manufacturing Facility

Table 7               Comparison of Single-use and Traditional Bioprocessing Systems

Table 8               Few Examples of Recent Approved Biologics and their Indications

Table 9               Facility Space Occupied by Stainless Steel and Single-use Systems (m2)

Table 10             Safety Concern of Final Product for Leachables/ Extractables

Table 11             Recent Advancements in Single-use Solutions

Table 12             Comparison of Single-use and Multi-use Bioreactors in terms of Process Time

Table 13             North America: Single-use Bioprocessing Market by Product 2020−2026 ($ million)

Table 14             North America: Single-use Bioprocessing Market by Product 2020−2026 (%)

Table 15             North America: Single-use Bioprocessing Market by Application 2020−2026 ($ million)

Table 16             North America: Single-use Bioprocessing Market by Application 2020−2026 (%)

Table 17             North America: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)

Table 18             North America: Single-use Bioprocessing Market by End-user 2020−2026 (%)

Table 19             Europe: Single-use Bioprocessing Market by Product 2020−2026 ($ million)

Table 20             Europe: Single-use Bioprocessing Market by Product 2020−2026 (%)

Table 21             Europe: Single-use Bioprocessing Market by Application 2020−2026 ($ million)

Table 22             Europe: Single-use Bioprocessing Market by Application 2020−2026 (%)

Table 23             Europe: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)

Table 24             Europe: Single-use Bioprocessing Market by End-user 2020−2026 (%)

Table 25             Currently Available Popular Biologics in APAC

Table 26             APAC: Single-use Bioprocessing Market by Product 2020−2026 ($ million)

Table 27             APAC: Single-use Bioprocessing Market by Product 2020−2026 (%)

Table 28             APAC: Single-use Bioprocessing Market by Application 2020−2026 ($ million)

Table 29             APAC: Single-use Bioprocessing Market by Application 2020−2026 (%)

Table 30             APAC: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)

Table 31             APAC: Single-use Bioprocessing Market by End-user 2020−2026 (%)

Table 32             Few Examples of Recently Approved Biosimilars in Australia

Table 33             Patent Expirations of Few Original Biologics

Table 34             Few Examples of Approved Biosimilars in India and their Therapeutic Areas

Table 35             Some Available Biologics in Latin America

Table 36             Single-use Bioprocessing - New Product Launches

Table 37             Latin America: Single-use Bioprocessing Market by Product 2020−2026 ($ million)

Table 38             Latin America: Single-use Bioprocessing Market by Product 2020−2026 (%)

Table 39             Latin America: Single-use Bioprocessing Market by Application 2020−2026 ($ million)

Table 40             Latin America: Single-use Bioprocessing Market by Application 2020−2026 (%)

Table 41             Latin America: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)

Table 42             Latin America: Single-use Bioprocessing Market by End-user 2020−2026 (%)

Table 43             Recently Launched Biosimilars in Middle East & Africa

Table 44             Middle East & Africa: Single-use Bioprocessing Market by Product 2020−2026 ($ million)

Table 45             Middle East & Africa: Single-use Bioprocessing Market by Product 2020−2026 (%)

Table 46             Middle East & Africa: Single-use Bioprocessing Market by Application 2020−2026 ($ million)

Table 47             Middle East & Africa: Single-use Bioprocessing Market by Application 2020−2026 (%)

Table 48             Middle East & Africa: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)

Table 49             Middle East & Africa: Single-use Bioprocessing Market by End-user 2020−2026 (%)

Table 50             Global Single-use Bioprocessing Market: Vendors Ranking

Table 51             Thermo Fisher Scientific: Major Product Offerings

Table 52             Sartorius Stedim Biotech: Major Product Offerings

Table 53             Danaher: Major Product Offerings

Table 54             Merck KGaA: Major Product Offerings

Table 55             Avantor: Major Product Offerings

Table 56             Applikon Biotechnology: Major Product Offerings

Table 57             Eppendorf: Major Product Offerings

Table 58             CESCO Bioengineering: Major Product Offerings

Table 59             Corning: Major Product Offerings

Table 60             Rentschler Biopharma SE: Major Product Offerings

Table 61             Entegris: Major Product Offerings

Table 62             Meissner Filtration Product: Major Product Offerings

Table 63             Parker-Hannifin Corporation: Major Product Offerings

Table 64             PBS Biotech: Major Product Offerings

Table 65             Saint-Gobain: Major Product Offerings

Table 66             Sentinel Process Systems: Major Product Offerings

Table 67             ABEC: Major Product Offerings

Table 68             Adolf Kühner: Major Product Offerings

Table 69             Charter Medical: Major Product Offerings

Table 70             Holland Applied Technologies: Major Product Offerings

Table 71             Repligen: Major Product Offerings

Table 72             Solaris Biotech Solutions: Major Product offerings

Table 73             3M Company: Major Product Offerings

Table 74             Lonza: Major Product Offerings

Table 75             Pneumatic Scale Angelus: Major Product Offerings

Table 76             ARTeSYN Biosolutions: Major Product Offerings

Table 77             Wego Group: Major Product Offerings

Table 78             Distek: Major Product Offerings

Table 79             New Horizon Biotech: Major Product Offerings

Table 80             OmniBRx Biotechnologies: Major Product Offerings

Table 81             Yposkesi: Major Product Offerings

Table 82             Charge Point Technologies: Major Product Offerings

Table 83             High Purity New England: Major Product Offerings

Table 84             PendoTECH: Major Product Offerings

Table 85             AdvantaPure: Major Product Offerings

Table 86             TBL Performance Plastics: Major Product Offerings

Table 87             Cellon: Major Product Offerings

Table 88             Sysbiotech: Major Product Offerings

Table 89             Broadley-James: Major Product Offerings

Table 90             CerCell: Major Product Offerings

Table 91             PreSens-Precision Sensing: Major Product Offerings

Table 92             Emerson Electric: Major Product Offerings

Table 93             CPC: Major Product Offerings

Table 94             Watson-Marlow Fluid Technology Group: Major Product Offerings

Table 95             Foxx Life Sciences: Major Product Offerings

Table 96             DRM: Major Product Offerings

Table 97             W.L. Gore & Associates: Major Product Offerings

Table 98             Global Single-use Bioprocessing Market by Product 2020−2026 ($ million)

Table 99             Global Single-use Bioprocessing Market by Product 2020−2026 (%)

Table 100           Single-use Bioprocessing Equipment by Geography 2020−2026 ($ million)

Table 101           Single-use Bioprocessing Equipment by Geography 2020−2026 (%)

Table 102           Simple & Peripheral Elements by Geography 2020−2026 ($ million)

Table 103           Simple & Peripheral Elements by Geography 2020−2026 (%)

Table 104           Global Single-use Bioprocessing Market by Application 2020−2026 ($ million)

Table 105           Global Single-use Bioprocessing Market by Application 2020−2026 (%)

Table 106           Monoclonal Antibodies by Geography 2020−2026 ($ million)

Table 107           Monoclonal Antibodies by Geography 2020−2026 (%)

Table 108           Vaccines by Geography 2020−2026 ($ million)

Table 109           Vaccines by Geography 2020−2026 (%)

Table 110           Cell Therapies by Geography 2020−2026 ($ million)

Table 111           Cell Therapies by Geography 2020−2026 (%)

Table 112           Others by Geography 2020−2026 ($ million)

Table 113           Others by Geography 2020−2026 (%)

Table 114           Global Single-use Bioprocessing by End-user 2020−2026 ($ million)

Table 115           Global Single-use Bioprocessing by End-user 2020−2026 (%)

Table 116           Biopharmaceutical Manufacturers by Geography 2020−2026 ($ million)

Table 117           Biopharmaceutical Manufacturers by Geography 2020−2026 (%)

Table 118           CMOs by Geography 2020−2026 ($ million)

Table 119           CMOs by Geography 2020−2026 (%)

Table 120           R&D Companies and Research Institutes by Geography 2020−2026 ($ million)

Table 121           R&D Companies and Research Institutes by Geography 2020−2026 (%)

Table 122           Global Single-use Bioprocessing Market by Method 2020−2026 ($ million)

Table 123           Global Single-use Bioprocessing Market by Method 2020−2026 (%)

Table 124           Global Single-use Bioprocessing Market by Geography 2020−2026 ($ million)

Table 125           Global Single-use Bioprocessing Market by Geography 2020−2026 (%)

Table 126           North America by Product 2020−2026 ($ million)

Table 127           North America by Product 2020−2026 (%)

Table 128           Europe by Product 2020−2026 ($ million)

Table 129           Europe by Product 2020−2026 (%)

Table 130           APAC by Product 2020−2026 ($ million)

Table 131           APAC by Product 2020−2026 (%)

Table 132           Latin America by Product 2020−2026 ($ million)

Table 133           Latin America by Product 2020−2026 (%)

Table 134           Middle East & Africa by Product 2020−2026 ($ million)

Table 135           Middle East & Africa by Product 2020−2026 (%)

Table 136           North America by Application 2020−2026 ($ million)

Table 137           North America by Application 2020−2026 (%)

Table 138           Europe by Application 2020−2026 ($ million)

Table 139           Europe by Application 2020−2026 (%)

Table 140           APAC by Application 2020−2026 ($ million)

Table 141           APAC by Application 2020−2026 (%)

Table 142           Latin America by Application 2020−2026 ($ million)

Table 143           Latin America by Application 2020−2026 (%)

Table 144           Middle East & Africa by Application 2020−2026 ($ million)

Table 145           Middle East & Africa by Application 2020−2026 (%)

Table 146           North America by End-user 2020−2026 ($ million)

Table 147           North America by End-user 2020−2026 (%)

Table 148           Europe by End-user 2020−2026 ($ million)

Table 149           Europe by End-user 2020−2026 (%)

Table 150           APAC by End-user 2020−2026 ($ million)

Table 151           APAC by End-user 2020−2026 (%)

Table 152           Latin America by End-user 2020−2026 ($ million)

Table 153           Latin America by End-user 2020−2026 (%)

Table 154           Middle East & Africa by End-user 2020−2026 ($ million)

Table 155           Middle East & Africa by End-user 2020−2026 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date